VTRS Short Volume

Viatris Inc. (VTRS) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry, with a market capitalization near $20.23B, listed on NASDAQ, employing roughly 32,000 people, carrying a beta of 0.87 to the broader market. Viatris Inc. Led by Scott Andrew Smith, public since 1980-03-17.

Short volume measures the number of shares sold short on a given day as reported by FINRA. Tracking short volume relative to total volume helps identify unusual bearish sentiment or short-squeeze potential.

Latest Date
2026-05-15
Short Volume
1.5M
Total Volume
3.7M
Short %
41.86%
30-Day Avg Short %
58.02%

Showing 30 days of FINRA short volume data for Viatris Inc..

Learn how short volume is reported and how to read the data →

VTRS most-active contracts

TypeStrikeExpirationVolumeOIIVBidAsk
CALL$10.00Jan 15, 2027358.4K55.4%$6.50$7.00

Top 1 contracts from the ORATS-sourced nightly scan; ranked by volume within the broader S&P 500/400/600 + ETF universe.

Frequently asked VTRS short volume questions

What is the daily VTRS short volume?
As of May 15, 2026, Viatris Inc. (VTRS) short volume is 1.5M shares against 3.7M total reported volume, or 41.86% short-side. Short volume measures shares sold short during the day; it is flow, not inventory.
How is VTRS short volume reported?
FINRA publishes the Daily Short Sale Volume File for trades reported to FINRA TRFs and the FINRA/Nasdaq ADF on a T+1 basis. The headline figure is the count of shares that printed at the short-sale or short-exempt tick across all reporting venues for the symbol; each exchange separately publishes its own daily short-sale data file.
What does VTRS short volume tell options traders?
Daily short-sale flow is one input that helps disambiguate dealer-hedging activity from directional bear flow when the chain shows fresh customer call inventory. It is not a clean MM-only proxy: the headline number mixes directional shorting, options-MM delta-hedging, ETF-creation arbitrage, and convertible-arb hedging. Cross-check against gamma-exposure and OI changes for a cleaner read.